1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Xiuning Le: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Osimertinib, Ramucirumab - Non Small Cell Lung Cancer, EGFR Gene Mutation | Phase 2 | Active not recruiting | Xiuning Le | 160 | 2019-07-25 | 2026-04-17 |
Carcinoma, Non-Small-Cell Lung (1) · Neoplasm Metastasis (1)
Ramucirumab (1) · osimertinib (1)
United States (1)